These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


146 related items for PubMed ID: 26983002

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The proteolytic activity of pregnancy-associated plasma protein-A is potentially regulated by stanniocalcin-1 and -2 during human ovarian follicle development.
    Jepsen MR, Kløverpris S, Bøtkjær JA, Wissing ML, Andersen CY, Oxvig C.
    Hum Reprod; 2016 Apr; 31(4):866-74. PubMed ID: 26874357
    [Abstract] [Full Text] [Related]

  • 3. Depot-specific and GH-dependent regulation of IGF binding protein-4, pregnancy-associated plasma protein-A, and stanniocalcin-2 in murine adipose tissue.
    Hjortebjerg R, Berryman DE, Comisford R, List EO, Oxvig C, Bjerre M, Frystyk J, Kopchick JJ.
    Growth Horm IGF Res; 2018 Apr; 39():54-61. PubMed ID: 29398370
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pregnancy-associated plasma proteins and Stanniocalcin-2 - Novel players controlling IGF-I physiology.
    Frystyk J, Teran E, Gude MF, Bjerre M, Hjortebjerg R.
    Growth Horm IGF Res; 2020 Apr; 53-54():101330. PubMed ID: 32693362
    [Abstract] [Full Text] [Related]

  • 7. Local IGF Bioactivity Associates with High PAPP-A Activity in the Pericardial Cavity of Cardiovascular Disease Patients.
    Hjortebjerg R, Rasmussen LM, Gude MF, Irmukhamedov A, Riber LP, Frystyk J, De Mey JGR.
    J Clin Endocrinol Metab; 2020 Nov 01; 105(11):. PubMed ID: 32875328
    [Abstract] [Full Text] [Related]

  • 8. Stanniocalcin-1 Potently Inhibits the Proteolytic Activity of the Metalloproteinase Pregnancy-associated Plasma Protein-A.
    Kløverpris S, Mikkelsen JH, Pedersen JH, Jepsen MR, Laursen LS, Petersen SV, Oxvig C.
    J Biol Chem; 2015 Sep 04; 290(36):21915-24. PubMed ID: 26195635
    [Abstract] [Full Text] [Related]

  • 9. Effects of mutated pregnancy-associated plasma protein-a on atherosclerotic lesion development in mice.
    Boldt HB, Bale LK, Resch ZT, Oxvig C, Overgaard MT, Conover CA.
    Endocrinology; 2013 Jan 04; 154(1):246-52. PubMed ID: 23161866
    [Abstract] [Full Text] [Related]

  • 10. Genetic deletion of pregnancy-associated plasma protein-A is associated with resistance to atherosclerotic lesion development in apolipoprotein E-deficient mice challenged with a high-fat diet.
    Harrington SC, Simari RD, Conover CA.
    Circ Res; 2007 Jun 22; 100(12):1696-702. PubMed ID: 17510462
    [Abstract] [Full Text] [Related]

  • 11. Novel Modulators of the Growth Hormone - Insulin-Like Growth Factor Axis: Pregnancy-Associated Plasma Protein-A2 and Stanniocalcin-2.
    Fujimoto M, Hwa V, Dauber A.
    J Clin Res Pediatr Endocrinol; 2017 Dec 30; 9(Suppl 2):1-8. PubMed ID: 29280739
    [Abstract] [Full Text] [Related]

  • 12. Pregnancy associated plasma protein-A2 (PAPP-A2) and stanniocalcin-2 (STC2) but not PAPP-A are associated with circulating total IGF-1 in a human adult population.
    Nimptsch K, Aydin EE, Chavarria RFR, Janke J, Poy MN, Oxvig C, Steinbrecher A, Pischon T.
    Sci Rep; 2024 Jan 20; 14(1):1770. PubMed ID: 38245583
    [Abstract] [Full Text] [Related]

  • 13. Increased activity of the metalloproteinase PAPP-A promotes diabetes-induced glomerular hypertrophy.
    Jepsen MR, Østergaard JA, Conover CA, Wogensen L, Birn H, Krag SP, Fenton RA, Oxvig C.
    Metabolism; 2022 Jul 20; 132():155218. PubMed ID: 35588861
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The IGF system in patients with inflammatory bowel disease treated with prednisolone or infliximab: potential role of the stanniocalcin-2 / PAPP-A / IGFBP-4 axis.
    Hjortebjerg R, Thomsen KL, Agnholt J, Frystyk J.
    BMC Gastroenterol; 2019 Jun 03; 19(1):83. PubMed ID: 31159802
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. p66Shc deletion confers vascular protection in advanced atherosclerosis in hypercholesterolemic apolipoprotein E knockout mice.
    Martin-Padura I, de Nigris F, Migliaccio E, Mansueto G, Minardi S, Rienzo M, Lerman LO, Stendardo M, Giorgio M, De Rosa G, Pelicci PG, Napoli C.
    Endothelium; 2008 Jun 03; 15(5-6):276-87. PubMed ID: 19065319
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.